Oral Vaccine for Dogs Against Echinococcus granulosus
Author Information
Author(s): Petavy Anne-Francoise, Hormaeche Carlos, Lahmar Samia, Ouhelli Hammou, Chabalgoity Alejandro, Marchal Thierry, Azzouz Samira, Schreiber Fernanda, Alvite Gabriela, Sarciron Marie-Elisabeth, Maskell Duncan, Esteves Adriana, Bosquet Georges
Primary Institution: Department of Parasitology and Medical Mycology, Lyon University, Lyon, France
Hypothesis
Can an oral recombinant vaccine effectively reduce Echinococcus granulosus infection in dogs?
Conclusion
The oral vaccine significantly decreased the parasite burden in vaccinated dogs by 70% to 80%.
Supporting Evidence
- The vaccine showed a significant decrease in the number of cestodes in vaccinated dogs compared to controls.
- Vaccinated dogs had a slower development rate of remaining worms.
- Results were consistent across trials conducted in Morocco and Tunisia.
Takeaway
The study tested a new vaccine for dogs that helps protect them from a parasite that can make humans sick, and it worked really well!
Methodology
The study involved two trials where dogs were vaccinated with a recombinant vaccine and then challenged with the parasite to assess the vaccine's efficacy.
Limitations
The study had a small sample size and one dog did not respond to the vaccine.
Participant Demographics
Dogs aged between 1 and 6 months from Morocco and Tunisia.
Statistical Information
P-Value
p<0.01
Confidence Interval
(170–1,130)
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website